Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 24.2 | 22.0 | 10.6 | 8.8 | 7.2 | 5.3 |
| Revenue growth | 10.0% | 108.0% | 20.4% | 21.9% | 36.8% | |
| Cost of goods sold | 3.5 | 3.3 | 2.4 | 2.3 | 2.1 | 1.9 |
| Gross profit | 20.7 | 18.7 | 8.2 | 6.5 | 5.1 | 3.3 |
| Gross margin | 85.6% | 84.9% | 77.5% | 74.2% | 70.8% | 63.4% |
| Sales and marketing | 1.0 | 0.8 | 0.3 | 0.3 | 0.3 | 0.2 |
| General and administrative | 10.5 | 7.9 | 10.9 | 2.8 | 1.8 | 1.7 |
| EBIT | 3.7 | 4.1 | -3.2 | 2.8 | 3.0 | 1.4 |
| EBIT margin | 15.2% | 18.5% | -30.1% | 31.7% | 41.3% | 26.5% |
| Pre-tax income | 3.3 | 3.8 | -3.2 | 2.8 | 3.0 | 1.4 |
| Income taxes | -0.8 | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 2.8 | 4.4 | -3.2 | 2.8 | 3.0 | 1.4 |
| Net margin | 11.7% | 19.9% | -30.1% | 31.7% | 41.3% | 26.5% |
| |
| Diluted EPS | $0.10 | $0.15 | ($0.13) | $0.13 | $0.14 | $1,398.26 |
| Shares outstanding (diluted) | 29.4 | 29.7 | 24.4 | 20.8 | 20.8 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|